Third, STING, as a key factor in the immune system, is closely related to immunomodulation, infection and cancer, and therefore targeted inhibitors of STING need to undergo complex biological evaluation and validation of their effects in different models to ensure the impact and safety on the whole immune system. This evidence concerns the gene STING1 and infection.